-
1
Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
Published 2024-09-01Subjects: “…Bortezomib…”
Get full text
Article -
2
Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis
Published 2017-05-01Subjects: “…Amyloidosis, VWS, Bortezomib…”
Get full text
Article -
3
Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma
Published 2010-07-01Subjects: “…bortezomib…”
Get full text
Article -
4
Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Reticular Plaques in a Patient With Multiple Myeloma
Published 2024-10-01Subjects: “…bortezomib…”
Get full text
Article -
5
Multiple myelomda kromozomal aberasyonlar: klinik sonuçlar ve bortezomib’ e yanıt
Published 2019-06-01Subjects: “…bortezomib…”
Get full text
Article -
6
Subcutaneous bortezomib might be standard of care for patients with multiple myeloma: a systematic review and meta-analysis
Published 2019-05-01Subjects: “…subcutaneous bortezomib…”
Get full text
Article -
7
Why bortezomib cannot go with ‘green’?
Published 2013-12-01Subjects: “…Bortezomib…”
Get full text
Article -
8
A feline case of multiple myeloma treated with bortezomib
Published 2022-11-01Subjects: Get full text
Article -
9
Bortezomib-Induced Perimyocarditis in a Multiple Myeloma Patient: A Case Report
Published 2021-12-01Subjects: “…bortezomib…”
Get full text
Article -
10
Comparison of Two Therapeutic Regimes, Lenalidomide with Dexamethasone and Thalidomide with Dexamethasone, in the Treatment of Multiple Myeloma at a Tertiary Care Hospital in India
Published 2015-05-01Subjects: “…bortezomib…”
Get full text
Article -
11
Treatment Outcomes with Reduced-Dose Bortezomib in Adult Patients with Multiple Myeloma: A Single-Center Experience
Published 2022-07-01Subjects: Get full text
Article -
12
Bortezomib in previously treated phosphatase and tension homology‐deficient patients with advanced intrahepatic cholangiocarcinoma: An open‐label, prospective and single‐centre pha...
Published 2024-05-01Subjects: “…bortezomib…”
Get full text
Article -
13
Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
Published 2021-08-01Subjects: “…bortezomib…”
Get full text
Article -
14
Goshajinkigan reduces bortezomib-induced mechanical allodynia in rats: Possible involvement of kappa opioid receptor
Published 2015-11-01Subjects: Get full text
Article -
15
Effective response with bortezomib retreatment in relapsed multiple myeloma
Published 2012-04-01Subjects: “…Bortezomib…”
Get full text
Article -
16
Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
Published 2019-02-01Subjects: Get full text
Article -
17
Experimental Study on the Mechanism of Reversal of Leukemia Multidrug Resistance by Proteasome Inhibitor Bortezomib
Published 2010-08-01Subjects: Get full text
Article -
18
Bortezomib neurotoxicity treatment of multiple myeloma: single center experience and literature review
Published 2022-11-01Subjects: “…bortezomib…”
Get full text
Article -
19
-
20
Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment
Published 2019-05-01Subjects: Get full text
Article